DE69521525T2 - Lignane, verfahren zu ihrer herstellung, ihre pharmazeutische compositionen und anwendungen - Google Patents
Lignane, verfahren zu ihrer herstellung, ihre pharmazeutische compositionen und anwendungenInfo
- Publication number
- DE69521525T2 DE69521525T2 DE69521525T DE69521525T DE69521525T2 DE 69521525 T2 DE69521525 T2 DE 69521525T2 DE 69521525 T DE69521525 T DE 69521525T DE 69521525 T DE69521525 T DE 69521525T DE 69521525 T2 DE69521525 T2 DE 69521525T2
- Authority
- DE
- Germany
- Prior art keywords
- lignans
- production
- pharmaceutical compositions
- agents
- lignane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/04—Seven-membered rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/04—Seven-membered rings not condensed with other rings
- C07D321/06—1,3-Dioxepines; Hydrogenated 1,3-dioxepines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP1995/004096 WO1997014670A1 (en) | 1995-10-18 | 1995-10-18 | Lignans, a process for their production and pharmaceutical compositions and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69521525D1 DE69521525D1 (de) | 2001-08-02 |
DE69521525T2 true DE69521525T2 (de) | 2002-04-25 |
Family
ID=8166108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69521525T Expired - Fee Related DE69521525T2 (de) | 1995-10-18 | 1995-10-18 | Lignane, verfahren zu ihrer herstellung, ihre pharmazeutische compositionen und anwendungen |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0797564B1 (de) |
JP (1) | JPH10511699A (de) |
AT (1) | ATE202551T1 (de) |
DE (1) | DE69521525T2 (de) |
WO (1) | WO1997014670A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1150967A4 (de) * | 1998-10-20 | 2003-03-05 | Shea Farn Yeh | Therapeutisch anwendbare verbindungen und methoden |
US6689809B2 (en) | 1999-03-30 | 2004-02-10 | Hormos Nutraceutical Oy Ltd. | Food additive or product or a pharmaceutical preparation, comprising hydroxymatairesinol |
US6451849B1 (en) * | 1999-03-30 | 2002-09-17 | Hormos Nutraceutical Oy Ltd. | Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol |
KR20010105064A (ko) * | 2000-05-18 | 2001-11-28 | 함종천 | 삼백초로부터 추출한 화합물 hnp-98701a,hnp-98701b 및 hnp-98701c의항암제로서의 용도와 이의 제조방법 및 이를 유효성분으로함유하는 항암제용 약학적 조성물 |
JP4213879B2 (ja) * | 2000-07-11 | 2009-01-21 | エルジー エレクトロニクス インコーポレイティド | 通信システム及び該システムの信号伝送方法 |
US6767565B2 (en) | 2001-03-22 | 2004-07-27 | Archer Daniels Midland Company | Process for obtaining lignan |
US20050080299A1 (en) * | 2002-01-09 | 2005-04-14 | Hormos Medical Corporation | Method for the preparation of matairesinol |
FI114022B (fi) * | 2002-01-17 | 2004-07-30 | Hormos Nutraceutical Oy Ltd | Menetelmä kasvislignaanien valmistamiseksi ja uusi välituote |
FI20020223A0 (fi) * | 2002-02-05 | 2002-02-05 | Hormos Nutraceutical Oy Ltd | Menetelmä biologisesti aktiivisen yhdisteen valmistamiseksi ja ryhmä uusia välituotteita |
US7528166B2 (en) | 2002-02-05 | 2009-05-05 | Hormos Medical Corporation | Lignan derivatives |
FI20020222A0 (fi) * | 2002-02-05 | 2002-02-05 | Hormos Nutraceutical Oy Ltd | Menetelmä nisäkäslignaanin valmistamiseksi |
US7048960B2 (en) | 2002-03-22 | 2006-05-23 | Glenn Roy Pizzey | High lignan flaxseed product and product by process |
MXPA05007571A (es) | 2003-01-17 | 2005-11-17 | Threshold Pharmaceuticals Inc | Tratamiento para hiperplasia protatica benigna utilizando agentes energoliticos. |
US7595078B2 (en) | 2005-03-15 | 2009-09-29 | Glanbia Nutritionals Ireland Limited | Methods of increasing flaxseed hull recovery and resultant flax products |
JP2011195465A (ja) * | 2010-03-17 | 2011-10-06 | Wakayama Prefecture | 桂皮酸誘導体の製造方法及び桂皮酸誘導体 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01228928A (ja) * | 1988-03-09 | 1989-09-12 | Tsumura & Co | リグナン類およびリグナン類を有効成分とする抗腫瘍剤 |
JPH0240323A (ja) * | 1988-07-28 | 1990-02-09 | Tsumura & Co | 免疫抑制剤 |
-
1995
- 1995-10-18 JP JP9515436A patent/JPH10511699A/ja active Pending
- 1995-10-18 EP EP95936521A patent/EP0797564B1/de not_active Expired - Lifetime
- 1995-10-18 DE DE69521525T patent/DE69521525T2/de not_active Expired - Fee Related
- 1995-10-18 AT AT95936521T patent/ATE202551T1/de not_active IP Right Cessation
- 1995-10-18 WO PCT/EP1995/004096 patent/WO1997014670A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
WO1997014670A1 (en) | 1997-04-24 |
EP0797564B1 (de) | 2001-06-27 |
ATE202551T1 (de) | 2001-07-15 |
JPH10511699A (ja) | 1998-11-10 |
DE69521525D1 (de) | 2001-08-02 |
EP0797564A1 (de) | 1997-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69521525T2 (de) | Lignane, verfahren zu ihrer herstellung, ihre pharmazeutische compositionen und anwendungen | |
DE69104991D1 (de) | Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen. | |
HU9401445D0 (en) | Nor-bile-acid derivatives, process for producing them and pharmaceutical compositions containing them | |
DE69431833D1 (de) | Antitumorverbindungen, pharmazeutische zusammensetzungen, verfahren zu ihrer herstellung und behandlungsmethoden | |
NZ337861A (en) | N-heterocyclic derivatives for treating multiple sclerosis, HIV dementia, Parkinson's disease, meningitis, atherosclerosis, cancer, inflammatory skin diseases | |
ATE174590T1 (de) | 4-aminopyridine, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel | |
ATE128458T1 (de) | Naphtylalkylamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE36699T1 (de) | Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung. | |
ATE45153T1 (de) | Benzisoselenazolthione, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische produkte. | |
TR199700878T1 (xx) | Monamin oksidaz B inhibit�rleri i�eren farmakotik kompozisyonlar. | |
ATE103893T1 (de) | 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung; diese derivate enthaltende pharmazeutische praeparate sowie deren verwendung als arzneimittel. | |
EP0460062A4 (en) | Method for the synthesis of huperzine a and analogs thereof and compounds useful therein | |
HUP9802121A2 (hu) | Imidazolinszármazékok, eljárás előállításukra és e vegyületeket tartalmazó gyógyszerkészítmények | |
ATE211474T1 (de) | Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente | |
ATE124953T1 (de) | Gallensäure-derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen daraus. | |
ATE4642T1 (de) | 2-hydroxyalkyl-3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
DK0579996T3 (da) | 5,10-Methylentetrahydrofolsyrecyclodextrin-inklusionsforbindelser | |
AT363936B (de) | Verfahren zur herstellung von neuen cyproheptadinderivaten und von deren pharmazeutisch verwendbaren salzen sowie optischen isomeren | |
ATE214051T1 (de) | Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
DE60041137D1 (de) | Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel | |
DE69917668D1 (de) | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung | |
ATE287895T1 (de) | Substituierte tetrahydropyranderivate sowie verfahren zu deren herstellung | |
DE68906519D1 (de) | Aryloxypropanolaminotetraline, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel. | |
ATE304527T1 (de) | Bis-basische verbindungen als tryptase- inhibitoren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
ATE19791T1 (de) | Polysaccharidsubstanz, verfahren zu deren herstellung, dieselbe enthaltende pharmazeutische zusammensetzungen sowie deren verwendung als medikamente. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |